Unprecedented improvement of ovarian cancer survival in BRCA-positive patients
The drug olaparib delays the recurrence of advanced ovarian cancer in woman who carry the BRCA gene.
Read more about 'Unprecedented improvement of ovarian cancer survival in BRCA-positive patients'...
Posted in BRCA; Posted 6 years ago by Andreas Obermair
Recent Posts
- What are the potential risks and complications associated with hysterectomy?
- How often will follow-up be performed to monitor for endometrial cancer recurrence?
- Safeguarding your recovery: Minimising the risks of postoperative hysterectomy complications
- Can aspirin help reduce risk of developing ovarian cancer?
- What is the self-collection test for cervical cancer screening? How does it work and who is eligible?